We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRMD icon
326
CorMedix
CRMD
$557M
$168K 0.02%
13,622
+1,451
+12% +$16K
LENZ
327
LENZ Therapeutics
LENZ
$158M
$166K 0.02%
5,653
+137
+2% +$3.73K
COGT icon
328
Cogent Biosciences
COGT
$6.76B
$164K 0.02%
22,868
+32
+0.1% +$177
SNDX icon
329
Syndax Pharmaceuticals
SNDX
$1.77B
$162K 0.02%
17,282
+161
+0.9% +$1.77K
AVXL icon
330
Anavex Life Sciences
AVXL
$316M
$158K 0.01%
17,147
+85
+0.5% +$726
ZTS icon
331
Zoetis
ZTS
$30.4B
$154K 0.01%
986
– –
QURE icon
332
uniQure
QURE
$3.13B
$153K 0.01%
10,996
-578
-5% -$7.78K
ZK
333
DELISTED
Zeekr
ZK
$153K 0.01%
6,000
-6,000
-50% -$148K
XERS icon
334
Xeris Biopharma Holdings
XERS
$1.55B
$150K 0.01%
32,167
+2,264
+8% +$10.4K
AVBP icon
335
ArriVent BioPharma
AVBP
$1.47B
$150K 0.01%
6,871
+112
+2% +$2.33K
GLUE icon
336
Monte Rosa Therapeutics
GLUE
$1.36B
$146K 0.01%
32,354
+20,031
+163% +$89.3K
ORIC icon
337
Oric Pharmaceuticals
ORIC
$1.43B
$145K 0.01%
14,278
+31
+0.2% +$208
REPL icon
338
Replimune Group
REPL
$1.28B
$144K 0.01%
15,483
+35
+0.2% +$305
VIR icon
339
Vir Biotechnology
VIR
$1.52B
$140K 0.01%
27,765
+256
+0.9% +$1.37K
PHAT icon
340
Phathom Pharmaceuticals
PHAT
$742M
$134K 0.01%
14,022
+307
+2% +$1.7K
DAWN
341
DELISTED
Day One Biopharmaceuticals
DAWN
$132K 0.01%
20,358
+28
+0.1% +$193
ANAB icon
342
AnaptysBio
ANAB
$1.69B
$131K 0.01%
5,901
-250
-4% -$5.23K
EYPT icon
343
EyePoint Inc
EYPT
$1.17B
$130K 0.01%
13,821
+131
+1% +$905
URGN icon
344
UroGen Pharma
URGN
$2.39B
$127K 0.01%
9,261
+797
+9% +$7.65K
STOK icon
345
Stoke Therapeutics
STOK
$2.13B
$124K 0.01%
10,966
+342
+3% +$3.25K
SANA icon
346
Sana Biotechnology
SANA
$1.13B
$124K 0.01%
45,302
+518
+1% +$1.07K
TSHA icon
347
Taysha Gene Therapies
TSHA
$2.05B
$121K 0.01%
52,527
+11,407
+28% +$24.8K
EOLS icon
348
Evolus
EOLS
$536M
$119K 0.01%
12,950
+249
+2% +$2.55K
RLAY icon
349
Relay Therapeutics
RLAY
$4.4B
$119K 0.01%
34,434
+431
+1% +$1.28K
ABUS icon
350
Arbutus Biopharma
ABUS
$907M
$119K 0.01%
38,467
+458
+1% +$1.52K
12 13
14
15 16

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.